U.S. Metals and Mining Stock News

Coherent overview and recent performance snapshot Coherent (COHR) has drawn investor attention after a sharp move in its share price, with recent data showing a month return of 32.97% and a past 3 months return of 55.29%. The stock closed at US$329.50, with year to date and 1 year total returns of 69.56% and 359.94% respectively, alongside reported annual revenue of US$6.29b and net income of US$192.23m. See our latest analysis for Coherent. Coherent’s recent 1 day share price return of 3.06%...

Wondering whether Delta Air Lines at around US$68.98 is offering good value or stretching expectations? This article will help you size up the stock through a clear valuation lens. The share price has moved by 0.8% over the last 7 days and 2.0% over the last 30 days, with a 1 year return of 58.0% and a 3 year return of 109.5%, while the year to date figure sits at a slight 0.1% decline. Recent headlines have focused on Delta Air Lines in the context of broader airline sector themes,...

Pool (POOL) has drawn fresh attention after its board expanded the share repurchase program to US$600.0m and lifted the quarterly dividend by 4% to US$1.30 per share, signaling shareholder friendly capital returns. See our latest analysis for Pool. Even with the enlarged buyback and higher dividend, Pool’s recent price action has been weak, with a 10.52% 7 day share price return decline and a 30.87% 1 year total shareholder return decline. This points to fading momentum despite steady recent...

Investors may be wondering whether Aurora Innovation's share price reflects its true worth, or if the market is mispricing the story right now. The stock recently closed at US$6.13, with returns of 24.8% over 7 days, 46.7% over 30 days, 58.4% year to date, and a 24.7% decline over the past year, alongside a very large gain over 3 years. Recent coverage has focused on how autonomous driving and AI related names are being reassessed by investors, as attention shifts to companies tied to real...

If you are wondering whether Corcept Therapeutics at around US$51.42 is attractively priced or already stretched, starting with a clear view of valuation can help frame your next move. The stock has seen sharp swings recently, with returns of 11.6% over 7 days, 22.5% over 30 days, 34.6% year to date, but a 29.3% decline over the past year and gains of 113.6% over 3 years and 143.7% over 5 years. Recent coverage has focused on how this price history shapes expectations for Corcept...

Recent share performance and business snapshot Without a specific headline event setting the tone, ACADIA Pharmaceuticals (ACAD) is drawing attention for its recent share performance and current fundamentals, which some investors may see as a prompt to reassess the stock. The company has a market value of about US$3.8b and last closed at US$21.95. Recent returns have been mixed, with a small move over the past week, a modest decline over the month, and a larger negative move over the past 3...

For investors considering whether Travelers Companies at around US$304.72 represents fair value or whether the price may be ahead of itself, this article examines what the available numbers indicate about the stock. The share price has moved by 0.7% over the past week, 4.9% over the last month, 6.8% year to date and 15.8% over the past year. These figures provide useful context before assessing the underlying value. Recent news coverage has focused on Travelers Companies as a major U.S...

What Airbnb’s recent performance signals for investors Without a specific news headline driving attention, Airbnb (ABNB) is on investors’ radar as its share price, recent returns, and profitability metrics offer fresh context for assessing the short term trade off between growth and value. See our latest analysis for Airbnb. With the share price at US$141.66 after a positive 1 day share price return of 0.93%, recent momentum has been shaped more by the 13.16% 30 day share price return and a...

Why CarGurus Stock Is on Investors’ Radar CarGurus (CARG) has drawn investor interest after recent trading left the shares around US$37.04, with returns over the past month and past 3 months outpacing its year to date performance. See our latest analysis for CarGurus. That recent move to US$37.04 follows a 10.4% 30 day share price return and a 14.3% 90 day share price return, set against a year to date share price return that is slightly negative and a 31.4% 1 year total shareholder return...

Why Wynn Resorts (WYNN) is on investors’ radar today Wynn Resorts (WYNN) continues to draw attention as investors weigh its recent share performance, with a month gain of 3.3% contrasted against a 1.4% decline over the past 3 months. See our latest analysis for Wynn Resorts. At a share price of $105.98, Wynn Resorts shows short term momentum with a 30 day share price return of 3.3%. The year to date share price return of a 13.5% decline contrasts with a 1 year total shareholder return of...

Recent share performance and business mix Healthpeak Properties (DOC) has seen mixed share performance recently, with a 1.5% gain over the past day, flat movement over the past week, a small rise over the past month, and a 4.8% decline over the past 3 months. The company, valued at about US$11.45b based on its recent share price of US$16.42, operates as a healthcare focused REIT with a diversified portfolio across outpatient medical, lab, continuing care retirement communities, and other...

Wondering whether Kraft Heinz is starting to look like value or still a value trap? This article walks through the key numbers that matter for you as a shareholder or potential buyer. The stock last closed at US$22.49, with returns of 2.5% over 7 days and 1.0% over 30 days, while year to date and 1 year returns sit at a 7.8% decline and a 16.5% decline respectively. These recent moves come against a backdrop of ongoing interest in large branded food companies and how they are adjusting...

FormFactor (FORM) is in focus after reporting record first quarter 2026 results, with revenue of US$226.1 million, expanded gross margins, and earnings above guidance, as demand in DRAM and networking probe cards drew strong investor attention. See our latest analysis for FormFactor. FormFactor shares have pulled back 11.4% over the past week after surging on the earnings release. However, the 30 day share price return of 36.2% and very large 1 year total shareholder return suggest momentum...

NIO (NIO) is back in focus after April deliveries reached 29,356 vehicles and the All New ES8 crossed 100,000 cumulative units, alongside expanded 900V technology collaboration with Onsemi and the Onvo L80 rollout. See our latest analysis for NIO. Despite the recent 1 day share price return of a 7.51% decline to $5.91 and a 7 day share price return of a 4.83% decline, NIO has a 90 day share price return of 25.74% and a 1 year total shareholder return of 46.65%, although the 5 year total...

Why Annaly’s latest earnings and activism push matter for shareholders Annaly Capital Management (NLY) has drawn fresh attention after reporting first quarter 2026 net income of US$282.65 million and earnings per share of US$0.33, alongside a shareholder proposal on written consents and a board backed campaign against it. See our latest analysis for Annaly Capital Management. The latest governance debate and Q1 earnings come on the back of an 8.0% 1 month share price return and a 35.2% 1 year...

Omega Healthcare Investors (OHI) opened 2026 with Q1 revenue of US$323 million and basic EPS of US$0.47, alongside funds from operations of US$249 million and FFO per share of US$0.84, setting a clear snapshot of cash generation and earnings at the start of the year. Over the past reported quarters, revenue has moved from US$277 million in Q1 2025 to US$319 million in Q4 2025 and EPS has ranged between US$0.34 and US$0.60 over that period. This gives investors a recent history of how the top...

In the first quarter of 2026, Veralto Corporation reported higher sales of US$1,422 million and net income of US$254 million compared with a year earlier, raised its full-year adjusted earnings per share guidance, invested about US$1 billion in acquiring In-Situ and GlobalVision, and completed a US$300.01 million buyback of 3,224,855 shares. The combination of stronger profitability, guidance uplift, portfolio expansion through acquisitions, and a completed share repurchase program...

Why Syndax Pharmaceuticals Stock Is Back in Focus After Q1 Results Syndax Pharmaceuticals (SNDX) is back on investors’ radar after reporting first quarter 2026 results that showed revenue of US$64.86 million and a narrower net loss of US$42.67 million versus a year earlier. The update provides fresh numbers to weigh against the recent share performance. This includes a return of 39.18% over the past year and a year-to-date return of negative 10.28%, from a last close of US$19.11. See our...

Wondering if American Healthcare REIT is reasonably priced at around US$50 a share, or if the market is getting ahead of itself? This article walks through what the current numbers actually say about value. The stock recently closed at US$50.15, with returns of 0.1% over 7 days, 5.5% over 30 days, 6.2% year to date and 57.7% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on American Healthcare...

Riot Platforms, Inc. recently reported first-quarter 2026 results, posting revenue of US$167.22 million, including US$33.2 million from its new data center segment, while recording a net loss of US$500.48 million or US$1.44 per share. The company’s pivot from pure Bitcoin mining to higher-margin data center and AI infrastructure operations gained traction, as AMD expanded its long-term lease at Riot’s Rockdale facility to 50 megawatts of contracted capacity, reinforcing the importance of...

Align Technology (ALGN) opened 2026 with Q1 revenue of about US$1.0 billion and basic EPS of US$1.58, setting the tone for how investors will read the rest of the year. The company has seen quarterly revenue move from US$979.3 million in Q1 2025 through US$995.2 million in Q4 2024 to just over US$1.0 billion in the latest quarter, while basic EPS over the same span ranged from US$1.27 in Q1 2025 to US$1.89 in Q4 2025 before landing at US$1.58 in Q1 2026. This provides a clear run-rate on both...

Why Kyivstar’s Ukraine investment program matters for VEON (NasdaqGS:VEON) VEON (NasdaqGS:VEON) is back in focus after Kyivstar completed a multi year, US$1.3b investment program in Ukraine ahead of schedule, surpassing the group’s original 2023 to 2027 commitment by 30%. See our latest analysis for VEON. VEON’s latest Ukraine update comes as the share price trades at US$49.74, with a 7.43% 1 month share price return but a 5.62% decline year to date. The 3 year total shareholder return of...

For investors considering whether Enova International at around US$169.41 is still reasonably priced or already demanding a premium, this article examines what the current share price might be implying about the business. The stock has delivered very strong longer term returns, with about 84.9% over 1 year, around 301.8% over 3 years and roughly 379.1% over 5 years, alongside a 24.7% move over the past month and a flat 7 day result. Recent coverage has focused on Enova International's...

Lockheed Martin, NYSE:LMT, has been selected by the U.S. Space Force to design and demonstrate space based interceptor prototypes. The work is part of the new Golden Dome missile defense shield aimed at countering ballistic, hypersonic, and cruise missile threats. Lockheed Martin is one of 12 vendors eligible for agreements valued in aggregate up to $3.2b. For investors watching NYSE:LMT, this contract slot comes as the stock trades around $517.97, with a 1 year return of 11.4% and a 5 year...